Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Halliday

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
JACC. Heart Failure|June 13, 2021
Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated CardiomyopathyBrian P Halliday, Ali Vazir, Ruth Owen, et al.
Nature Cardiovascular Research|May 16, 2025
Developing cardiac digital twin populations powered by machine learning provides electrophysiological insights in conduction and repolarizationShuang Qian, Devran Ugurlu, Elliot Fairweather, et al.
European Journal of Heart Failure|November 23, 2020
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HFBrian P Halliday, Ruth Owen, John Gregson, et al.
Scientific Reports|October 13, 2021
A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacementVassilios S Vassiliou, Menelaos Pavlou, Tamir Malley, et al.
European Journal of Heart Failure|September 30, 2024
Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remissionLeanne Cheng, Daniel Hammersley, Aaraby Ragavan, et al.
European Journal of Heart Failure|June 5, 2018
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathyBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
Heart (British Cardiac Society)|August 12, 2021
Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathyUpasana Tayal, John Gregson, Rachel Buchan, et al.
European Journal of Heart Failure|February 15, 2020
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance studyUpasana Tayal, Ricardo Wage, Simon Newsome, et al.
Journal of the American College of Cardiology|September 1, 2024
Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic CardiomyopathyDaniel J Hammersley, Abbasin Zegard, Emmanuel Androulakis, et al.
JACC. Cardiovascular Imaging|July 18, 2021
Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-FractionAmrit S Lota, Adam Tsao, Ruth Owen, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
JACC. Heart Failure|June 13, 2021
Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated CardiomyopathyBrian P Halliday, Ali Vazir, Ruth Owen, et al.
Nature Cardiovascular Research|May 16, 2025
Developing cardiac digital twin populations powered by machine learning provides electrophysiological insights in conduction and repolarizationShuang Qian, Devran Ugurlu, Elliot Fairweather, et al.
European Journal of Heart Failure|November 23, 2020
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HFBrian P Halliday, Ruth Owen, John Gregson, et al.
Scientific Reports|October 13, 2021
A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacementVassilios S Vassiliou, Menelaos Pavlou, Tamir Malley, et al.
European Journal of Heart Failure|September 30, 2024
Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remissionLeanne Cheng, Daniel Hammersley, Aaraby Ragavan, et al.
European Journal of Heart Failure|June 5, 2018
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathyBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
Heart (British Cardiac Society)|August 12, 2021
Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathyUpasana Tayal, John Gregson, Rachel Buchan, et al.
European Journal of Heart Failure|February 15, 2020
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance studyUpasana Tayal, Ricardo Wage, Simon Newsome, et al.
Journal of the American College of Cardiology|September 1, 2024
Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic CardiomyopathyDaniel J Hammersley, Abbasin Zegard, Emmanuel Androulakis, et al.
JACC. Cardiovascular Imaging|July 18, 2021
Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-FractionAmrit S Lota, Adam Tsao, Ruth Owen, et al.
Pageof 9